SXTP – 60 degrees pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership [Yahoo! Finance]
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its price target raised by analysts at HC Wainwright from $6.00 to $24.00. They now have a "buy" rating on the stock.
60 Degrees Pharma announces 1-for-4 reverse stock split; shares up [Seeking Alpha]
Form 8-K 60 DEGREES PHARMACEUTICA For: Jan 20
Form 8-K 60 DEGREES PHARMACEUTICA For: Jan 08
Form 4 60 DEGREES PHARMACEUTICA For: Dec 15 Filed by: DOW GEOFFREY S
Form 4 60 DEGREES PHARMACEUTICA For: Dec 10 Filed by: DOW GEOFFREY S
Form 10-Q 60 DEGREES PHARMACEUTICA For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.